Get started
Author

Linda N. Liu

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
2015 · Kristin J. Lastwika, Willie Wilson, et al. · Cancer Research · 785
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
2019 · Jun Wang, Jingwei Sun, et al. · Nature Medicine · 686
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
1999 · H Hosoi, M B Dilling, et al. · PubMed · 312
Studies on the Mechanism of Resistance to Rapamycin in Human Cancer Cells
1998 · Hajime Hosoi, Michael B. Dilling, et al. · Molecular Pharmacology · 173
p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
2001 · S Huang, L N Liu, et al. · PubMed · 132
Highly Efficient, Large Volume Flow Electroporation
2002 · Lin-Hong Li, Rama Shivakumar, et al. · Technology in Cancer Research & Treatment · 64
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms
2013 · Joseph R. Podojil, Linda N. Liu, et al. · Journal of Autoimmunity · 56
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
2021 · Gehua Zhen, Yang Dan, et al. · Bone Research · 47
PDF
Comparison of Drug and Cell-Based Delivery: Engineered Adult Mesenchymal Stem Cells Expressing Soluble Tumor Necrosis Factor Receptor II Prevent Arthritis in Mouse and Rat Animal Models
2013 · Linda N. Liu, Gang Wang, et al. · Stem Cells Translational Medicine · 47
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex
2018 · Joseph R Podojil, Ming-Yi Chiang, et al. · The Journal of Immunology · 42
Mutations in the Endo Domain of Sindbis Virus Glycoprotein E2 Block Phosphorylation, Reorientation of the Endo Domain, and Nucleocapsid Binding
1996 · Linda N. Liu, Heuiran Lee, et al. · Virology · 29
PDF
Delivery of Whole Tumor Lysate into Dendritic Cells for Cancer Vaccination
2008 · Linda N. Liu, Rama Shivakumar, et al. · Methods in molecular biology · 22
Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells
2004 · Jonathan M Weiss, Rama Shivakumar, et al. · Cancer Gene Therapy · 22
Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL
2013 · Lawrence A. Wolfraim, Masashi Takahara, et al. · International Immunopharmacology · 19
Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer
2022 · Saba Shafi, Thazin Nwe Aung, et al. · Laboratory Investigation · 18
Development of an immunohistochemical assay for Siglec-15
2022 · Saba Shafi, Thazin Nwe Aung, et al. · Laboratory Investigation · 14
Efficient Responses in a Murine Renal Tumor Model by Electroloading Dendritic Cells With Whole-Tumor Lysate
2005 · Jonathan M Weiss, Cornell Allen, et al. · Journal of Immunotherapy · 13
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia
2023 · Claire E. Pillsbury, Jodi Dougan, et al. · Cancer Research Communications · 11
PDF
Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes
2026 · Nicholas J. Campion, Dioni‐Pinelopi Petsiou, et al. · International Forum of Allergy & Rhinology · 5
Siglec-15 Is a Novel Immunomodulatory Protein and Therapeutic Target in Acute Lymphoblastic Leukemia
2021 · Claire E. Pillsbury, Jairo A. Fonseca, et al. · Blood · 4
A Practical Approach for Achieving Clinical Immunotherapy of CLL with hCD40L- and hIL-2-Expressing Autologous Tumor Cells.
2005 · Joseph C. Fratantoni, Linhong Li, et al. · Blood · 3
Abstract 4266: Discovery and characterization of a novel LRRC15-targeting antibody drug conjugate (ADC) for the treatment of solid tumors
2025 · Shanshan Yan, Bing Wan, et al. · Cancer Research · 2
A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells
2021 · Linjie Tian, Ana Paucarmayta, et al. · Blood · 2
A phase 1/2, open-label, dose-escalation, safety and tolerability study of NC410 in subjects with advanced or metastatic solid tumors.
2021 · Martin Gutierrez, Filip Janku, et al. · Journal of Clinical Oncology · 2
Siglec-15 Is a Novel Immunomodulatory Protein and Therapeutic Target in Childhood Leukemia
2020 · Claire E. Pillsbury, Jairo A. Fonseca, et al. · Blood · 2
Works count: 84
Citation count: 2,515
H-index: 15
I10-index: 18
Year
Topic
Type